English

Inhalation Sciences AB (publ) releases Annual Report 2022 including Audit Report

Report this content

(Stockholm, Sweden, 11 April 2023) Inhalation Sciences AB announces that it is now releasing an updated version of its Annual Report 2022 that includes the Audit Report (Revisionsberättelsen).

To read the whole report (in Swedish), visit: http://inhalation.se/investors/finansiella-rapporter/

For more information about Inhalation Sciences, please contact:

Manoush Masarrat, CEO

E-mail: Manoush.masarrat@inhalation.se

Mobile: +46 (0)73 628 9153

About Inhalation Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.

Subscribe

Documents & Links